Product Images Enspryng
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 19 images provide visual information about the product associated with Enspryng NDC 50242-007 by Genentech Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1 - enspryng 01
This appears to be a statistical report of a clinical trial comparing the efficacy of a drug called ENSPRYNG to a placebo. The data seems to indicate that ENSPRYNG is significantly effective in reducing the risk of relapse in patients. The report includes information on the hazard ratio, proportion relapse-free at 96 weeks, and time to relapse in weeks. The sample sizes are N=23 for the placebo and N=41 for ENSPRYNG.*
Figure 2 - enspryng 02
This is a statistical report for a medical trial with a drug called ENSPRYNG. The report includes data on the risk reduction of relapse, hazard ratio, and proportion of patients who are relapse-free at Week 96. The results show that the drug is effective in preventing relapse in patients with this medical condition.*
Image - enspryng 03
Figure A - enspryng 04
This appears to be a set of instructions or warning labels for a medical device. The text mentions "Activation guards," which may be safety features. There is also a warning not to touch a barrel and a notation about the expiration date of a plunger. However, without more context, it is difficult to determine the exact function or purpose of the device.*
Figure B - enspryng 05
The text describes a "needle-shield" that is extended and locked, but without any context or further information it is not possible to determine what type of device or instrument it is referring to or how it is used.*
Figure C - enspryng 06
Figure D - enspryng 07
Figure E - enspryng 08
Figure F - enspryng 09
This is a set of instructions regarding how to inspect a medical device, possibly a syringe, before use. It outlines three steps which are checking the expiration date, ensuring the liquid inside is safe for use, and checking the syringe for damage.*
Figure G - enspryng 10
Figure H - enspryng 11
Figure I - enspryng 12
Figure J - enspryng 13
Figure K - enspryng 14
Figure L - enspryng 15
Figure M - enspryng 16
Figure N - enspryng 17
Figure O - enspryng 18
PRINCIPAL DISPLAY PANEL - 120 mg/mL Syringe Carton - enspryng 19
Enspryng (satralizumab-mwge) is an injection medication that comes in a single-dose prefilled syringe. The medication should be refrigerated at 2°C to 8°C (36°F to 46°F) in its original carton to protect it from light. Freezing and shaking should be avoided. The medication guide enclosed in the package must be given to each patient by the pharmacist. This medication is distributed by Genentech and has the National Drug Code (NDC) 50242-007-01.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.